The FDA has expanded the emergency use authorization (EUA) of the COVID-19 vaccine booster does to include all fully vaccinated individuals aged 18 or older.
Previously, the FDA authorized a booster dose after the completion of a primary vaccine series for individuals 65 years of age of older, individuals 18 through 64 years of age at high risk for severe COVID-19 or who work or live in high-risk settings to COVID-19. This put a limit on who could receive a booster dose and caused some uncertainty around who qualified to receive it.
Now, “The FDA has determined that currently available data support expanding the eligibility of a single booster dose of the Moderna and Pfizer-BioNTech COVID-19 vaccines to individuals 18 years of age and older,” said Peter Marks, MD, PhD, director of the FDA’s Center for Biologics Evaluation and Research, in a press release. He also added, “Streamlining the eligibility criteria and making booster doses available to all individuals 18 years of age and older will also help to eliminate confusion about who may receive a booster dose and ensure booster doses are available to all who may need one.”
Visit Drug Topics and Pharmacy Times for more updates.